FindTrial
Sign In

Obesity Paradox in Non Valvular Atrial Fibrillation Regarding Outcomes: Fact or Fiction

Obesity Paradox in Non Valvular Atrial Fibrillation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03904329
Enrollment
1
Registered
2019-04-05
Start date
2020-10-01
Completion date
2023-10-01
Last updated
2022-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity Paradox

Brief summary

Obesity paradox In patient with non valvular atrial fibrillation

Detailed description

Study role of obesity in outcomes of anticoagulation in patients with non valvular atrial fibrillation

Interventions

DRUGOral Anticoagulant

Oral tablets of anti coagulations either warfare or NOACs

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* patients presented with non valvular AF * patients on oral anticoagulant

Exclusion criteria

* valvular AF * Mental illness * History of cerebrovascular stroke * history of bleeding tendency * history of Chronic renal failure

Design outcomes

Primary

MeasureTime frameDescription
Correlation between obesity and outcomes in non valvular atrial fibrillationSixth monthsTo study effect of obesity in outcomes of non valvular atrial fibrillation regarding the effect of obesity in the outcome of anticoagulants

Countries

Egypt

Contacts

Primary ContactChristen Henan, Ressident
Christenamir@yahoo.com01201558854
Backup ContactMahmmoed Abd e El saAbour, Assissetant professor
M_abd_elsabour@yahoo.com01001202779

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026